Canadian Medical Center reports SAR 15.7M profit in 2023

26/03/2024 Argaam Exclusive

View other reports

Canadian Medical Center Co. reported a net profit of SAR 15.7 million for 2023, compared to SAR 15.65 million a year earlier.

Financials (M)

Item	2022	2023	Change‬
Revenues	81.23	100.34	23.5 %
Gross Income	24.97	31.54	26.3 %
Operating Income	17.26	15.90	(7.9 %)
Net Income	15.65	15.71	0.4 %
Average Shares	77.00	77.00	-
EPS (Riyals)	0.20	0.20	0.4 %

Revenue increased by 23.53% year-on-year to SAR 100 million in 2023 due to expansions in Saudi Arabia.

Net profit was also supported by the increase in operating income. The provision for doubtful debts rose by SAR 5.87 million.

Current Half Annual Comparison (M)

Compared With The

Item	H2 2022	H2 2023	Change‬
Revenues	42.31	55.13	30.3 %
Gross Income	12.34	17.33	40.4 %
Operating Income	8.15	7.59	(6.8 %)
Net Income	7.72	7.71	(0.1 %)
Average Shares	77.00	77.00	-
EPS (Riyals)	0.10	0.10	(0.1 %)

Item	H1 2023	H2 2023	Change‬
Revenues	45.22	55.13	21.9 %
Gross Income	14.21	17.33	21.9 %
Operating Income	8.31	7.59	(8.6 %)
Net Income	8.00	7.71	(3.7 %)
Average Shares	77.00	77.00	-
EPS (Riyals)	0.10	0.10	(3.7 %)

Total shareholders’ equity, no minority interest, stood at SAR 91.83 million by Dec. 31, 2023, compared to SAR 87.01 million a year ago.

Historical Data
Period	Revenue (SAR mln)	Net profit (SAR mln)	EPS (SAR /share)
H1 2020	29.83	8.4	0.11
H2 2020	34.38	7.75	0.10
H1 2021	30.18	4.96	0.06
H2 2021	40.46	9.1	0.12
H1 2022	38.92	7.94	0.10
H2 2022	42.31	7.71	0.10
H1 2023	45.22	8.00	0.10
H2 2023	55.12	7.71	0.10

View more financial results

Financial results (Million)

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
H1 2014	-	-	-	-	-	-
H2 2014	-	-	-	-	-	-
2014	-	-	-	-	-	-
H1 2015	-	-	-	-	-	-
H2 2015	-	-	-	-	-	-
2015	-	-	-	-	-	-
H1 2016	-	-	-	-	-	-
H2 2016	-	-	-	-	-	-
2016	-	-	-	-	-	-
H1 2017	-	-	-	-	-	-
H2 2017	-	-	-	-	-	-
2017	-	-	-	-	-	-
H1 2018	-	-	-	-	-	-
H2 2018	-	-	-	-	-	-
2018	-	-	-	-	-	-
H1 2019	-	-	-	-	-	-
H2 2019	-	-	-	-	-	-
2019	53.56	-	21.29	-	16.30	-
H1 2020	29.83	-	12.22	-	8.72	-
H2 2020	34.38	-	11.80	-	8.44	-
2020	64.22	19.9 %	24.03	12.9 %	17.16	5.3 %
H1 2021	30.18	1.2 %	12.39	1.4 %	6.51	(25.4 %)
H2 2021	40.46	17.7 %	12.80	8.4 %	9.80	16.0 %
2021	70.64	10.0 %	25.19	4.9 %	16.30	(5.0 %)
H1 2022	38.92	28.9 %	12.63	1.9 %	9.11	40.1 %
H2 2022	42.31	4.6 %	12.34	(3.6 %)	8.15	(16.9 %)
2022	81.23	15.0 %	24.97	(0.9 %)	17.26	5.9 %
H1 2023	45.22	16.2 %	14.21	12.5 %	8.31	(8.8 %)
H2 2023	55.13	30.3 %	17.33	40.4 %	7.59	(6.8 %)
2023	100.34	23.5 %	31.54	26.3 %	15.90	(7.9 %)

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
2014	-	-	-	-	-	-
2015	-	-	-	-	-	-
2016	-	-	-	-	-	-
2017	-	-	-	-	-	-
2018	-	-	-	-	-	-
2019	53.56	-	21.29	-	16.30	-
2020	64.22	19.9 %	24.03	12.9 %	17.16	5.3 %
2021	70.64	10.0 %	25.19	4.9 %	16.30	(5.0 %)
2022	81.23	15.0 %	24.97	(0.9 %)	17.26	5.9 %
2023	100.34	23.5 %	31.54	26.3 %	15.90	(7.9 %)

Profit Performance (Million)

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
H1 2014	-	-	-	-	-	-
H2 2014	-	-	-	-	-	-
2014	-	-	-	-	-	-
H1 2015	-	-	-	-	-	-
H2 2015	-	-	-	-	-	-
2015	-	-	-	-	-	-
H1 2016	-	-	-	-	-	-
H2 2016	-	-	-	-	-	-
2016	-	-	-	-	-	-
H1 2017	-	-	-	-	-	-
H2 2017	-	-	-	-	-	-
2017	-	-	-	-	-	-
H1 2018	-	-	-	-	-	-
H2 2018	-	-	-	-	-	-
2018	-	-	-	-	-	-
H1 2019	-	-	-	-	-	-
H2 2019	-	-	-	-	-	-
2019	14.87	-	0.19	-	14.87	0.19
H1 2020	8.40	-	0.11	-	8.40	0.11
H2 2020	7.75	-	0.10	-	7.75	0.10
2020	16.15	8.6 %	0.21	-	16.15	0.21
H1 2021	4.96	(40.9 %)	0.06	-	4.96	0.06
H2 2021	9.10	17.4 %	0.12	-	9.10	0.12
2021	14.06	(12.9 %)	0.18	-	14.06	0.18
H1 2022	7.94	59.9 %	0.10	-	7.94	0.10
H2 2022	7.72	(15.2 %)	0.10	-	7.72	0.10
2022	15.65	11.3 %	0.20	-	15.65	0.20
H1 2023	8.00	0.8 %	0.10	-	8.00	0.10
H2 2023	7.71	(0.1 %)	0.10	-	7.71	0.10
2023	15.71	0.4 %	0.20	-	15.71	0.20

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	EPS Before XO Items
2014	-	-	-	-	-	-
2015	-	-	-	-	-	-
2016	-	-	-	-	-	-
2017	-	-	-	-	-	-
2018	-	-	-	-	-	-
2019	14.87	-	0.19	-	14.87	0.19
2020	16.15	8.6 %	0.21	-	16.15	0.21
2021	14.06	(12.9 %)	0.18	-	14.06	0.18
2022	15.65	11.3 %	0.20	-	15.65	0.20
2023	15.71	0.4 %	0.20	-	15.71	0.20

Profitability

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
H1 2014	-	-	-
H2 2014	-	-	-
2014	-	-	-
H1 2015	-	-	-
H2 2015	-	-	-
2015	-	-	-
H1 2016	-	-	-
H2 2016	-	-	-
2016	-	-	-
H1 2017	-	-	-
H2 2017	-	-	-
2017	-	-	-
H1 2018	-	-	-
H2 2018	-	-	-
2018	-	-	-
H1 2019	-	-	-
H2 2019	-	-	-
2019	39.75 %	33.03 %	27.77 %
H1 2020	-	-	-
H2 2020	37.42 %	31.13 %	25.15 %
2020	37.42 %	31.13 %	25.15 %
H1 2021	37.48 %	28.00 %	19.70 %
H2 2021	35.66 %	27.24 %	19.91 %
2021	35.66 %	27.24 %	19.91 %
H1 2022	32.04 %	27.32 %	21.47 %
H2 2022	30.74 %	25.12 %	19.27 %
2022	30.74 %	25.12 %	19.27 %
H1 2023	30.34 %	22.31 %	17.96 %
H2 2023	31.43 %	17.57 %	15.66 %
2023	31.43 %	17.57 %	15.66 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
2014	-	-	-
2015	-	-	-
2016	-	-	-
2017	-	-	-
2018	-	-	-
2019	39.75 %	33.03 %	27.77 %
2020	37.42 %	31.13 %	25.15 %
2021	35.66 %	27.24 %	19.91 %
2022	30.74 %	25.12 %	19.27 %
2023	31.43 %	17.57 %	15.66 %

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
H1 2014	-	-	-
H2 2014	-	-	-
H1 2015	-	-	-
H2 2015	-	-	-
H1 2016	-	-	-
H2 2016	-	-	-
H1 2017	-	-	-
H2 2017	-	-	-
H1 2018	-	-	-
H2 2018	-	-	-
H1 2019	-	-	-
H2 2019	-	-	-
H1 2020	40.97 %	32.99 %	28.15 %
H2 2020	34.33 %	29.52 %	22.55 %
H1 2021	41.06 %	26.26 %	16.44 %
H2 2021	31.64 %	27.96 %	22.49 %
H1 2022	32.45 %	26.66 %	20.40 %
H2 2022	29.17 %	23.70 %	18.24 %
H1 2023	31.43 %	21.01 %	17.70 %
H2 2023	31.44 %	14.75 %	13.98 %

Per Share Data (Riyal)

Compared With The

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
H1 2014	-	-	-	-
H2 2014	-	-	-	-
H1 2015	-	-	-	-
H2 2015	-	-	-	-
H1 2016	-	-	-	-
H2 2016	-	-	-	-
H1 2017	-	-	-	-
H2 2017	-	-	-	-
H1 2018	-	-	-	-
H2 2018	-	-	-	-
H1 2019	-	-	-	-
H2 2019	-	-	-	-
H1 2020	77.00	-	-	0.19
H2 2020	77.00	0.21	0.21	1.20
H1 2021	77.00	0.17	0.17	1.26
H2 2021	77.00	0.18	0.18	1.23
H1 2022	77.00	0.22	0.22	1.18
H2 2022	77.00	0.20	0.20	1.13
H1 2023	77.00	0.20	0.20	1.18
H2 2023	77.00	0.20	0.20	1.19

Period	Shares Outstanding (M)	EPS (Riyal)	Adjusted EPS (Riyal)	Book Value (BV)
2014	-	-	-	-
2015	-	-	-	-
2016	-	-	-	-
2017	-	-	-	-
2018	-	-	-	-
2019	77.00	0.19	0.19	0.15
2020	77.00	0.21	0.21	1.20
2021	77.00	0.18	0.18	1.23
2022	77.00	0.20	0.20	1.13
2023	77.00	0.20	0.20	1.19

Multiple Ratios (End of Period Price)

Compared With The

Period	P/E	Adjusted P/E	Price/book
H1 2014	-	-	-
H2 2014	-	-	-
H1 2015	-	-	-
H2 2015	-	-	-
H1 2016	-	-	-
H2 2016	-	-	-
H1 2017	-	-	-
H2 2017	-	-	-
H1 2018	-	-	-
H2 2018	-	-	-
H1 2019	-	-	-
H2 2019	-	-	-
H1 2020	-	-	-
H2 2020	-	-	-
H1 2021	-	-	-
H2 2021	47.36	47.36	7.05
H1 2022	22.96	22.96	4.32
H2 2022	22.13	22.13	3.98
H1 2023	27.97	27.97	4.84
H2 2023	28.62	28.62	4.90

Period	P/E	Adjusted P/E	Price/book
2014	-	-	-
2015	-	-	-
2016	-	-	-
2017	-	-	-
2018	-	-	-
2019	-	-	-
2020	-	-	-
2021	47.36	47.36	7.05
2022	22.13	22.13	3.98
2023	28.62	28.62	4.90

Business Segments (Million)

Compared With The

Period	Medical Clinics Sector	Medical Clinics Project Contracts Sector

Period	Medical Clinics Sector	Medical Clinics Project Contracts Sector
2020	2.02	62.20
2021	1.93	68.72
2022	2.29	78.94
2023	3.15	97.20

Share Price

Canadian Medical Center Co. (CMCER)

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Canadian Medical Center reports SAR 15.7M profit in 2023

View other reports

Financials (M)

Current Half Annual Comparison (M)

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million)

Revenue by Business Segment (Latest) 2023 Q4

Share Price

Canadian Medical Center Co. (CMCER)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

×

Canadian Medical Center reports SAR 15.7M profit in 2023

View other reports

Financials (M)

Current Half Annual Comparison (M)

Financial results (Million)

Financial results (Million)

Profit Performance (Million)

Profit Performance (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million) 2023

Revenue by Business Segment (Latest) 2023 Q4

Share Price

Canadian Medical Center Co. (CMCER)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Business Segments (Million)